FREE SHIPPING ON ORDERS OVER $150

glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Frontiers | Understanding the action

$22.99

Quantity
- +
Description

Int J Endocrinol 2020

glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Frontiers | Understanding the action

Duffy, A

glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Frontiers | Understanding the action

J Clin Invest 113, 635645 (2004)

glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Frontiers | Understanding the action

This is a medical emergency that requires immediate attention

glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Frontiers | Understanding the action

You may also like

recommand products